Dr. Exner is leading multiple large international trials, is a world authority on arrhythmias, has over 300 peer-reviewed publications and abstracts and multiple patents related to using electrocardiogram (ECG) signals to evaluate cardiac structure and the risk of serious arrhythmias. He is actively engaged in research with multiple small and large biotech companies in Canada and beyond and has obtained over $50 million in funding from peer-reviewed and industry sources over the past two decades. Dr. Exner has authored or co-authored more than 185 articles, book chapters, and abstracts, including publications in leading medical journals such as the New England Journal of Medicine, Circulation, and the Journal of the American College of Cardiology.